776 related articles for article (PubMed ID: 2200176)
1. The influence of MHC and non-MHC genes on the nature of murine cardiac allograft rejection. I. Kinetic analysis of mononuclear cell infiltrate and MHC-class I/class II expression in donor tissue.
Wang YC; Mayne A; Sell KW; Ahmed-Ansari A
Transplantation; 1990 Aug; 50(2):313-24. PubMed ID: 2200176
[TBL] [Abstract][Full Text] [Related]
2. T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas.
Kelly KE; Hertz MI; Mueller DL
Transplantation; 1998 Sep; 66(6):764-71. PubMed ID: 9771840
[TBL] [Abstract][Full Text] [Related]
3. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells.
Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN
Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467
[TBL] [Abstract][Full Text] [Related]
4. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
5. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
Rolink AG; Pals ST; Gleichmann E
J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
[TBL] [Abstract][Full Text] [Related]
6. The role of host T cell subsets in bone marrow rejection directed to isolated major histocompatibility complex class I versus class II differences of bm1 and bm12 mutant mice.
Vallera DA; Taylor PA; Sprent J; Blazar BR
Transplantation; 1994 Jan; 57(2):249-56. PubMed ID: 7906058
[TBL] [Abstract][Full Text] [Related]
7. Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts.
Ishii D; Rosenblum JM; Nozaki T; Schenk AD; Setoguchi K; Su CA; Gorbacheva V; Baldwin WM; Valujskikh A; Fairchild RL
J Immunol; 2014 Oct; 193(7):3816-24. PubMed ID: 25172484
[TBL] [Abstract][Full Text] [Related]
8. Tolerance induction of allo-class II H-2 antigen-reactive L3T4+ helper T cells and prolonged survival of the corresponding class II H-2-disparate skin graft.
Hori S; Sato S; Kitagawa S; Azuma T; Kokudo S; Hamaoka T; Fujiwara H
J Immunol; 1989 Sep; 143(5):1447-52. PubMed ID: 2527264
[TBL] [Abstract][Full Text] [Related]
9. Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.
Hori S; Kitagawa S; Iwata H; Ochiai T; Isono K; Hamaoka T; Fujiwara H
J Exp Med; 1992 Jan; 175(1):99-109. PubMed ID: 1730930
[TBL] [Abstract][Full Text] [Related]
10. Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.
Qian S; Fu F; Li Y; Lu L; Rao AS; Starzl TE; Thomson AW; Fung JJ
Immunology; 1996 May; 88(1):124-9. PubMed ID: 8707337
[TBL] [Abstract][Full Text] [Related]
11. Suppression extends to major histocompatibility antigens linked to tolerizing minor histocompatibility antigens, but not the other way round.
Bemelman F; Yong SL; Tissingh R; Schellekens P; ten Berge I
Transpl Int; 2005 Apr; 18(4):423-8. PubMed ID: 15773962
[TBL] [Abstract][Full Text] [Related]
12. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
Moser M; Sharrow SO; Shearer GM
J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
[TBL] [Abstract][Full Text] [Related]
13. Immune and non-immune factors in cryopreserved tissues.
Tomita Y; Yoshikawa M; Zhang Qi; Uchida T; Nakashima Y; Sueishi K; Nomoto K; Yasui H
J Heart Lung Transplant; 2003 May; 22(5):560-7. PubMed ID: 12742419
[TBL] [Abstract][Full Text] [Related]
14. Induction of linked suppression in addition to the donor H-2 class I-specific unresponsiveness in recipient T cells by transfusing class I plus class II-disparate, but not class I alone-disparate, bone marrow cells.
Muraoka S
Cell Immunol; 1990 Jun; 128(1):261-76. PubMed ID: 1971530
[TBL] [Abstract][Full Text] [Related]
15. Survival of MHC-deficient mouse heterotopic cardiac allografts.
Campos L; Naji A; Deli BC; Kern JH; Kim JI; Barker CF; Markmann JF
Transplantation; 1995 Jan; 59(2):187-91. PubMed ID: 7839439
[TBL] [Abstract][Full Text] [Related]
16. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.
Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG
J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860
[TBL] [Abstract][Full Text] [Related]
17. Graft-specific MHC class II gene expression in response to allogeneic stimulus in heterotopic murine cardiac allografts.
Xu R; Burdick JF; Scott A; Beschorner WE; Adler W; Kittur DS
Immunology; 1992 Feb; 75(2):361-5. PubMed ID: 1551698
[TBL] [Abstract][Full Text] [Related]
18. Ductal lesions of exocrine glands and insulitis induced by L3T4+ T cells following graft-versus-host reaction due to major histocompatibility complex class II disparity.
Saitoh T; Fujiwara M; Asakura H
Clin Immunol Immunopathol; 1990 Dec; 57(3):339-50. PubMed ID: 1978809
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness.
Bishop DK; DeBruyne LA; Chan S; Xu S; Eichwald EJ
Transpl Immunol; 1995 Sep; 3(3):222-8. PubMed ID: 8581410
[TBL] [Abstract][Full Text] [Related]
20. CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts.
Nozaki T; Rosenblum JM; Schenk AD; Ishii D; Fairchild RL
Am J Transplant; 2009 Oct; 9(10):2251-61. PubMed ID: 19656127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]